Global Folic Acid Market Size, Share & Trends Analysis Report, By Form (Tablets, Capsules and Softgels, Powder, and Others), By Application (Dietary Supplements, Pharmaceuticals, Food and Beverages, and Others) and Forecast, 2020-2026.
The global folic acid market is estimated to witness significant growth during the forecast period. Rising applications in pharmaceuticals and dietary supplements are primarily driving the growth of the market. Folic acid is the completely oxidized monoglutamate kind of the vitamin used in most dietary supplements and fortified foods. Some dietary supplements also consist of folate in the monoglutamyl form, 5-methyl-THF (also referred to as methylfolate, L-5- MTHF, and 5-MTHF, L-methylfolate). Folic acid is available in prenatal vitamins and multivitamins, supplements containing only folic acid, and supplements that contain other B-complex vitamins. Common doses of folic acid range from 400 to 800 micrograms (mcg) in supplements for adults and 200 to 400 mcg in children’s multivitamins.
400 mcg/day folic acid from dietary supplements and/or fortified foods is required in women of childbearing age along with the folate offered by a diverse diet. For most pregnant women, the American College of Obstetricians and Gynecologists suggests a prenatal vitamin supplement to ensure that they get suitable amounts of folic acid and other nutrients. There are several disorders in which folate may play a crucial role, which includes CVD and stroke, autism spectrum disorder; cancer; Alzheimer’s disease; dementia, NTDs; cognitive function, and depression; preterm birth, congenital heart defects, and other congenital anomalies.
Geographically, in 2019, Asia-Pacific witnessed considerable growth in the market owing to the rising number of patients with folate-deficiency and increasing awareness regarding nutritional food and dietary supplements in the region. Significant focus on infant nutrition and nutrition for pregnant women is primarily encouraging the adoption of folic acid-enriched products in the region. North America is significantly driven by the emerging demand for dietary supplements in the region. As per the Council for Responsible Nutrition (CRN) 2019 survey, 77% of the US adults take dietary supplements. This results in an emerging demand for folic acid to support the body to produce and maintain new cells.
Key players in the market include Koninklijke DSM N.V., BASF SE, Cadila Healthcare Ltd., Merck KGaA, and Jiangxi Tianxin Pharmaceutical Co., Ltd. Jiangxi Tianxin Pharmaceutical Co., Ltd. main products comprise folic acid, vitamins B1 and B6, and ascorbyl palmitate, which are primarily applied to food additives, bulk pharmaceutical chemicals, and feed additives. The company has set up R&D center and the Jiangxi Vitamin Engineering Technology Research Center in Shanghai for developing, producing, and selling the valuable products. DSM offers high-quality and reliable forms of vitamin B9 that can be formulated for a range of applications for a range of foods, including breakfast cereals, flour, salt, as well as infant nutrition, beverages, and soft drinks products.
Research Methodology
The market study of the global folic acid market is incorporated by extensive primary and secondary research conducted. Secondary research has been conducted to refine the available data to breakdown the market in various segments, derive total market size, market forecast and growth rate. Different approaches have been worked on to derive the market value and market growth rate. The team collects facts and data related to the market from different geography to provide a better regional outlook.
In the report, the country-level analysis is provided by analyzing various regional players, regional tax laws and policies, consumer behavior and macro-economic factors. Numbers extracted from secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. This enables the analyst to derive the closest possible figures without any major deviations in the actual number. The analysts try to contact as many executives, managers, key opinion leaders and industry experts. Primary research brings authenticity in the reports.
Secondary Sources Include
The report provides in-depth analysis on market size, intended quality of the service preferred by consumers. The report will serve as a source for 360-degree analysis of the market thoroughly integrating different models.
Market Segmentation
The Report Covers
The global folic acid market is estimated to witness significant growth during the forecast period. Rising applications in pharmaceuticals and dietary supplements are primarily driving the growth of the market. Folic acid is the completely oxidized monoglutamate kind of the vitamin used in most dietary supplements and fortified foods. Some dietary supplements also consist of folate in the monoglutamyl form, 5-methyl-THF (also referred to as methylfolate, L-5- MTHF, and 5-MTHF, L-methylfolate). Folic acid is available in prenatal vitamins and multivitamins, supplements containing only folic acid, and supplements that contain other B-complex vitamins. Common doses of folic acid range from 400 to 800 micrograms (mcg) in supplements for adults and 200 to 400 mcg in children’s multivitamins.
400 mcg/day folic acid from dietary supplements and/or fortified foods is required in women of childbearing age along with the folate offered by a diverse diet. For most pregnant women, the American College of Obstetricians and Gynecologists suggests a prenatal vitamin supplement to ensure that they get suitable amounts of folic acid and other nutrients. There are several disorders in which folate may play a crucial role, which includes CVD and stroke, autism spectrum disorder; cancer; Alzheimer’s disease; dementia, NTDs; cognitive function, and depression; preterm birth, congenital heart defects, and other congenital anomalies.
Geographically, in 2019, Asia-Pacific witnessed considerable growth in the market owing to the rising number of patients with folate-deficiency and increasing awareness regarding nutritional food and dietary supplements in the region. Significant focus on infant nutrition and nutrition for pregnant women is primarily encouraging the adoption of folic acid-enriched products in the region. North America is significantly driven by the emerging demand for dietary supplements in the region. As per the Council for Responsible Nutrition (CRN) 2019 survey, 77% of the US adults take dietary supplements. This results in an emerging demand for folic acid to support the body to produce and maintain new cells.
Key players in the market include Koninklijke DSM N.V., BASF SE, Cadila Healthcare Ltd., Merck KGaA, and Jiangxi Tianxin Pharmaceutical Co., Ltd. Jiangxi Tianxin Pharmaceutical Co., Ltd. main products comprise folic acid, vitamins B1 and B6, and ascorbyl palmitate, which are primarily applied to food additives, bulk pharmaceutical chemicals, and feed additives. The company has set up R&D center and the Jiangxi Vitamin Engineering Technology Research Center in Shanghai for developing, producing, and selling the valuable products. DSM offers high-quality and reliable forms of vitamin B9 that can be formulated for a range of applications for a range of foods, including breakfast cereals, flour, salt, as well as infant nutrition, beverages, and soft drinks products.
Research Methodology
The market study of the global folic acid market is incorporated by extensive primary and secondary research conducted. Secondary research has been conducted to refine the available data to breakdown the market in various segments, derive total market size, market forecast and growth rate. Different approaches have been worked on to derive the market value and market growth rate. The team collects facts and data related to the market from different geography to provide a better regional outlook.
In the report, the country-level analysis is provided by analyzing various regional players, regional tax laws and policies, consumer behavior and macro-economic factors. Numbers extracted from secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. This enables the analyst to derive the closest possible figures without any major deviations in the actual number. The analysts try to contact as many executives, managers, key opinion leaders and industry experts. Primary research brings authenticity in the reports.
Secondary Sources Include
- Financial reports of companies involved in the market
- Authentic public databases
- Whitepapers, research-papers, and news blogs
- Company websites and their product catalog
The report provides in-depth analysis on market size, intended quality of the service preferred by consumers. The report will serve as a source for 360-degree analysis of the market thoroughly integrating different models.
Market Segmentation
- Global Folic Acid Market Research and Analysis, By Form
- Global Folic Acid Market Research and Analysis, By Application
The Report Covers
- Comprehensive research methodology of the global folic acid market.
- This report also includes a detailed and extensive market overview with key analyst insights.
- Exhaustive analysis of macro and micro factors influencing the market guided by key recommendations.
- Analysis of regional regulations and other government policies impacting the global folic acid market.
- Insights about market determinants which are stimulating the global folic acid market.
- Detailed and extensive market segments with regional distribution of forecast revenues.
- Extensive profiles and recent developments of market players.
Table of Contents
1. Report Summary
2. Market Overview and Insights
3. Competitive Landscape
4. Market Determinants
5. Market Segmentation
6. Regional Analysis
7. Company Profiles
LIST OF TABLES
LIST OF FIGURES
Companies Mentioned
A selection of companies mentioned in this report includes:
- Accord-UK Ltd.
- Amway Corp.
- BASF SE
- Cadila Healthcare Ltd.
- Changzhou Yabang Pharmaceutical Co., Ltd.
- Cipla Ltd.
- Cytoplan Ltd.
- Elmed Life Sciences Pvt. Ltd.
- Emcure Pharmaceuticals Ltd.
- General Nutrition Corp. (GNC)
- Healthy Hey LLP
- INLIFE Pharma Pvt. Ltd.
- Jiangxi Tianxin Pharmaceutical Co., Ltd.
- Kirkman Group Inc.
- Koninklijke DSM N.V.
- Medicamen Biotech Ltd.
- Merck KGaA
- NOW Health Group, Inc.
- The Nature's Bounty Co.
- West-Coast Pharmaceutical Works Ltd.
- Xinfa Pharmaceutical Co., Ltd.